Taiwanese Dermatological Association Consensus for the Prevention and Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Related Skin Toxicities

    Chia‐Yu Chu, Kuan‐Yu Chen, John Wen‐Cheng Chang … Weiming Wang
    Studysummary This report presents the Taiwanese Dermatological Association's 2016 consensus on defining and managing skin toxicities from EGFR-TKI treatments, providing comprehensive guidelines for clinicians in Taiwan.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker Expert Review of Anticancer Therapy · 2013

    Related research 1

    1. The Management of EGFR Inhibitor Adverse Events: A Case Series and Treatment Paradigm International Journal of Dermatology · 2012